首页> 外国专利> COMPOSITIONS AND METHODS FOR PREDICTING ANALYTIC SUCCESS OF T-CELL QUANTIFICATION AND T-CELL RECEPTOR SEQUENCING

COMPOSITIONS AND METHODS FOR PREDICTING ANALYTIC SUCCESS OF T-CELL QUANTIFICATION AND T-CELL RECEPTOR SEQUENCING

机译:预测T细胞定量和T细胞受体测序分析成功率的组合物和方法

摘要

Provided are compositions, including products of manufacture and kits, and methods, for predicting the successful construction of a genomic T-Cell Receptor (TCR) library from a tissue sample; or predicting the successful sequencing of a TCR sequence from a tissue sample, wherein optionally the tissue sample comprises or is derived from a biopsy or a Formalin-Fixation and Paraffin Embedding (FFPE) sample, and optionally the tissue sample is a human or an animal sample. In alternative embodiments, provided herein are assays for predicting successful library construction and sequencing of a TCR chain. In alternative embodiments, the T cell is a tumor infiltrating lymphocyte (TIL). The results of methods provided herein can generate a prediction as to the success of assays used for quantifying T-cells and sequencing T-cell receptors, including any commercially available assay (e.g., ImmunoSeq, Adaptive Biotechnologies, Seattle, Wash.) to effectively assess TCR quantity and clonality.
机译:提供了用于预测从组织样品成功构建基因组T细胞受体(TCR)文库的组合物,包括生产的产品和试剂盒以及方法。或预测组织样品中TCR序列的成功测序,其中任选地,组织样品包含活检或福尔马林固定和石蜡包埋(FFPE)样品或衍生自该样品,并且任选地,组织样品是人或动物样品。在替代实施方案中,本文提供了用于预测成功的文库构建和TCR链测序的测定法。在替代实施方案中,T细胞是肿瘤浸润淋巴细胞(TIL)。本文提供的方法的结果可以产生关于用于定量T细胞和对T细胞受体进行测序的测定法的成功的预测,包括任何可以有效评估的市售测定法(例如,ImmunoSeq,Adaptive Biotechnologies,Seattle,Washington)。 TCR数量和克隆性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号